Furthermore, the phenomenon of recovery of reduced cell proliferative capacity caused by overexpressing BIRC5 or introducing si-p21 into RUNX1-suppressed cells was not a complete recovery, but only a partial, suggesting that the effect of RUNX1 on GBM proliferation is a partial effect. The gene discussed is CDKN1A; the disease is glioblastoma.